From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades

From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades

Developing biomarkers for accurately predicting the efficacy of immune checkpoint inhibitor (ICI) therapies is conducive to avoiding unwanted side effects and economic burden. At the moment, the quantification of programmed cell death ligand 1 (PD-L1) in tumor tissues is clinically used as one of th...

Full description

Bibliographic Details
Main Authors: Xuan Zhao, Yulin Bao, Bi Meng, Zijian Xu, Sijin Li, Xu Wang, Rui Hou, Wen Ma, Dan Liu, Junnian Zheng, Ming Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
PD-L1
immune checkpoint inhibitors
tumor immunotherapy
biomarker
liquid biopsy
tumor microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.920021/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.920021/full

Similar Items